h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
How-To Videos
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
TRNDi002-B
Registration Summary
:
A
P
E
C
iPSC HT519B
The cell line is
not submitted
yet.
(only basic data is shown)
General
iPSC Line
hPSCreg name
TRNDi002-B
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
TRNDi002-B (RRID:CVCL_UL09)
Alternative name(s)
iPSC HT519B
iPSC line type
Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines
No similar lines found.
Last update
27th March 2019
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
NIH/NCATS-TRND Branch (TRND)
External iPSC Databases
Cellosaurus
CVCL_UL09
Wikidata
Q98133573
General iPSC Information
Publications
Li R et al. Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene. Stem cell research. 2019 Jan;34:101362.
Farkhondeh A et al. Induced pluripotent stem cells for neural drug discovery. Drug discovery today. 2019 Apr;24(4):992-999.
Hong J et al. Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene. Stem cell research. 2019 May;37:101451.
Huang W et al. An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene. Stem cell research. 2019 May;37:101427.
Miller DB et al. CompoundHetVIP: Compound Heterozygous Variant Identification Pipeline. F1000Research. 2020;9:1211.
Pradhan M et al. An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene. Stem cell research. 2021 Jul;54:102400.
Sasserath T et al. An induced pluripotent stem cell-derived NMJ platform for study of the NGLY1-Congenital Disorder of Deglycosylation. Advanced therapeutics. 2022 Nov;5(11).
Abbott J et al. Generation and characterization of NGLY1 patient-derived midbrain organoids. Frontiers in cell and developmental biology. 2023;11:1039182.
iPSC Derivation
General
Login to share your feedback, experiences or results with the research community.